Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuropharmacology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2013.12.007PMID 24334069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual effects of L-DOPA on nigral dopaminergic neurons.

  2013cited by this paper
• Endocannabinoids Generated by Ca2+ or by Metabotropic Glutamate Receptors Appear to Arise from Different Pools of Diacylglycerol Lipase

  2011cited by this paper
• Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.

  2011cited by this paper
• Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.

  2011cited by this paper
• Pathological basal ganglia activity in movement disorders.

  2011cited by this paper
• Postsynaptic diacylglycerol lipase α mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex

  2011cited by this paper
• Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex.

  2010cited by this paper
• Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.

  2010cited by this paper
• Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

  2010cited by this paper
• Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.

  2010cited by this paper
• The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats.

  2010cited by this paper
• Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses

  2010cited by this paper
• Glutamate, excitotoxicity, and programmed cell death in Parkinson disease.

  2009cited by this paper
• Acute action of rotenone on nigral dopaminergic neurons – involvement of reactive oxygen species and disruption of Ca2+ homeostasis

  2009influential reference
• Lipidomic methodologies applicable to the study of endocannabinoids and related compounds: Endocannabinoidomics

  2009cited by this paper
• The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine.

  2009influential reference
• Functional type I vanilloid receptor expression by substantia gelatinosa neurons of trigeminal subnucleus caudalis in mice.

  2009cited by this paper
• Endocannabinoid-mediated control of synaptic transmission.

  2009influential reference
• Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization

  2009influential reference
• Basal ganglia control of substantia nigra dopaminergic neurons.

  2009cited by this paper
• The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons

  2008influential reference
• Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.

  2008influential reference
• Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling

  2008influential reference
• Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.

  2008cited by this paper
• Retrograde Regulation of GABA Transmission by the Tonic Release of Oxytocin and Endocannabinoids Governs Postsynaptic Firing

  2007cited by this paper
• Basal ganglia macrocircuits.

  2007cited by this paper
• Levodopa‐induced dyskinesias

  2007cited by this paper
• Postsynaptic origin of CB1‐dependent tonic inhibition of GABA release at cholecystokinin‐positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus

  2007cited by this paper
• Phasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation

  2007cited by this paper
• GABAergic control of substantia nigra dopaminergic neurons.

  2007cited by this paper
• N-Arachidonoyl-Dopamine Tunes Synaptic Transmission onto Dopaminergic Neurons by Activating both Cannabinoid and Vanilloid Receptors

  2007influential reference
• A role for endocannabinoids in the generation of parkinsonism and levodopa‐induced dyskinesia in MPTP‐lesioned non‐human primate models of Parkinson's disease

  2005cited by this paper
• Retrograde Endocannabinoid Signaling in a Postsynaptic Neuron/Synaptic Bouton Preparation from Basolateral Amygdala

  2005cited by this paper
• Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids

  2005cited by this paper
• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

  2005influential reference
• Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

  2004cited by this paper
• Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids

  2004influential reference
• Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.

  2003cited by this paper
• Glutamate Spillover in the Striatum Depresses Dopaminergic Transmission by Activating Group I Metabotropic Glutamate Receptors

  2003cited by this paper
• CB1 cannabinoid receptor signalling in Parkinson's disease.

  2003cited by this paper
• An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

  2002influential reference
• SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

  2002cited by this paper
• Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain.

  2002cited by this paper
• Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.

  2002cited by this paper
• Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus

  2002influential reference
• Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area

  2002cited by this paper
• Differential Subcellular Localization of mGluR1a and mGluR5 in the Rat and Monkey Substantia Nigra

  2001influential reference
• The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice.

  2001cited by this paper
• Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors.

  2001influential reference
• Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

  2001influential reference
• Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

  2001cited by this paper
• Group I mGluRs coupled to G proteins are regulated by tyrosine kinase in dopamine neurons of the rat midbrain.

  2001cited by this paper
• Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

  2001cited by this paper
• N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

  2000cited by this paper
• Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms

  1999cited by this paper
• Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.

  1999cited by this paper
• Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat.

  1998cited by this paper
• LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

  1998cited by this paper
• Glutamate Metabotropic Receptor Agonists Depress Excitatory and Inhibitory Transmission on Rat Mesencephalic Principal Neurons

  1997cited by this paper
• Metabotropic glutamate receptor‐mediated inhibition and excitation of substantia nigra dopamine neurons

  1997cited by this paper
• Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

  1997influential reference
• In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

  1996cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Partial purification of a diacylglycerol lipase from bovine aorta.

  1994cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Actions of levodopa on rat substantia nigra zona compacta neurons.

  1992cited by this paper
• Themed Issue: Cannabinoids in Biology and Medicine, Part I Prospects for Cannabinoid Therapies in Basal Ganglia Disorders

  year unknowncited by this paper

• A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB1 and CB2 Receptor Signalling

  2025cites this paper
• Mechanisms of endocannabinoid control of synaptic plasticity.

  2021cites this paper
• N‐arachidonoyl dopamine inhibits epithelial–mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol

  2021cites this paper
• The Cannabinoid CB1 Receptor in Schizophrenia.

  2020cites this paper
• The Neuroprotective Effect of N-Docosahexaenoyldopamine on Degenerating Dopaminergic Neurons of the Mesencephalon

  2020cites this paper
• Differential mechanisms of tolerance induced by NMDA and 3,5‐dihydroxyphenylglycine (DHPG) preconditioning

  2020cites this paper
• Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood

  2020cites this paper
• The Role of Lipids in Parkinson’s Disease

  2019cites this paper
• Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases.

  2019cites this paper
• The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice

  2018cites this paper
• Pulse-Width Modulation of Optogenetic Photo-Stimulation Intensity for Application to Full-Implantable Light Sources

  2017cites this paper
• N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities

  2017influential citation
• Pharmacological Aspects of NMDA Receptors, mGluR5, and Endocannabinoids

  2017cites this paper
• Étude in vivo des interactions entre le système endocannabinoïde et l’axe corticotrope chez l’homme

  2017influential citation
• Identification of N‐arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors

  2016influential citation
• Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.

  2016cites this paper
• Endocannabinoid metabolism by cytochrome P450 monooxygenases.

  2015cites this paper
• Excitatory drive from the Subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids.

  2015cites this paper
• N-Acyldopamines and N-Acylserotonins: From Synthetic Pharmacological Tools to Endogenous Multitarget Mediators

  2015cites this paper
• Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

  2015cites this paper
• Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids

  2015cites this paper
• Prostaglandins and Other Lipid Mediators eview ndocannabinoid metabolism by cytochrome P 450 monooxygenases

  2014cites this paper
• Endocannabinoid-mediated retrograde modulation of synaptic transmission.

  2014cites this paper
• Synaptic effects of cannabinoids

  2014cites this paper